🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James R. Berenson

Oncotherapeutics (United States)

ORCID: 0000-0003-1587-6104

Also affiliated with Institute for Myeloma & Bone Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen.

4 citations

Tanya M. Spektor, Carley Turner, Alexa Cohen, Alberto Bessudo, Haresh Jhangiani +11 more

0 citations

Kam C. Yeung, Michael A. Palladino, James R. Berenson, Benjamin Bonavida, Stavroula Baritaki